Loading
Ferozsons Laboratories Limited is a listed company. Its insiders report their share dealings to PSX (SECP). Over the twelve months to 25 October 2026, 2 filings were filed, from 0 insiders.
Not one open-market sale was filed. On the buying side, 0 insiders reported 1 purchase totalling €128. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €128, disclosed on 19 June 2026.
The clock since the last published purchase (19 June 2026) now reads 128 days.
Compared with its exchange (282 companies, median 3 filings), a count of 2 filings is below the norm.
These figures are compiled from regulatory filings published by PSX (SECP). They describe what insiders did and are not a recommendation.
· cache
6 of 6 declarations
Ferozsons Laboratories Limited is a pharmaceutical company based in Pakistan, specializing in the manufacturing and distribution of pharmaceutical products. It is listed on the Karachi Stock Exchange under the symbol XKAR.